Matia Mobility Secures HCPCS Code for Tek RMD: A Groundbreaking Solution Now Covered by Medicare, Commercial Insurance, and the VA

Matia Mobility, a leader in durable medical equipment, is proud to announce that the Centers for Medicare & Medicaid Services (CMS) has granted a HCPCS (Healthcare Common Procedure Coding System) code for the Tek RMD (Robotic Mobilization Device). This milestone makes standing mobility more accessible to individuals with walking disabilities confined to wheelchairs, providing new opportunities for independence and improving both physical and mental well-being.

The Tek RMD, now covered by Medicare, commercial insurance, and the U.S. Veterans Administration, is revolutionizing mobility by enabling users to stand and move at eye level, empowering them to participate fully in daily life. This includes tasks like cooking, reaching high shelves, and engaging in conversations and social interactions from a standing position, which promotes both confidence and social inclusion.

Benefits of Standing: More Than Just Mobility

The ability to stand has long been recognized for its numerous health benefits. Physically, standing helps improve circulation, reduce muscle atrophy, enhance bone density, and aid in digestive functions. These advantages are especially critical for individuals who spend extended periods in a seated position. Mentally, standing fosters a sense of empowerment and autonomy, reducing the emotional and psychological strain often associated with being wheelchair-bound. Standing upright allows users to see the world from a new perspective, positively impacting their self-esteem and social interactions.

Beyond the physical and mental health benefits, standing at eye level enables individuals to carry out activities of daily living (ADLs) more easily. Whether it’s preparing meals, doing household chores, going to work, or even pursuing hobbies and interests, the Tek RMD allows users to regain control over their lives in ways that were previously unimaginable. This is particularly impactful for veterans and others with service-related disabilities, who can now experience a new level of freedom and dignity.

Expanded Coverage and Accessibility

With the HCPCS code now approved, individuals across the country can access the Tek RMD with greater ease, and financial barriers are significantly reduced. The device’s inclusion in Medicare coverage is complemented by support from major commercial insurers, making this innovative solution even more accessible. The U.S. Veterans Administration’s coverage of the Tek RMD is another major step in honoring and supporting veterans, particularly those who have sustained mobility-limiting injuries during their service.

“We are incredibly excited about this development,” said Steven Boal, CEO of Matia Mobility. “Receiving the HCPCS code from CMS means more people will have access to the life-changing benefits of the Tek RMD. Whether through Medicare, private insurance, or VA benefits, our goal is to help as many individuals as possible reclaim their independence and improve their quality of life.”

Matia Mobility has made insurance prior authorization accessible via its website at https://www.matiamobility.com.

For more information about the Tek RMD and how to access coverage, visit https://www.matiamobility.com.

About Matia Mobility

Matia Mobility is committed to providing innovative mobility solutions that enhance independence, dignity, and quality of life for individuals with disabilities. With a focus on cutting-edge technology and personalized care, Matia Mobility helps people of all ages and abilities experience new possibilities in mobility and daily living. Matia Mobility, reimagining mobility for people with walking disabilities.

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.